Anthropometric Characteristics of Elite and Olympic Mexican Track and Field Athletes (ANTHROLYMPMX)

May 10, 2024 updated by: Cesar Octavio Ramos Garcia, PhD, Iberoamerican Institute of Sports Science and Human Movement
Sport specialization requires an understanding of morphological variability to optimize performance. However, the current literature lacks a detailed analysis of the anthropometric profile of track and field athletes, especially in Latin America. Additionally, the five-way fractionation method of body mass has been under-documented. These gaps highlight the need for more research to maximize the potential of athletes, particularly in emerging countries like Mexico. This study aims to determine the anthropometric characteristics of elite and Olympic Mexican track and field athletes. A descriptive cross-sectional study will be conducted. Forty-three anthropometric variables will be assessed to characterize the athlete´s physical composition using the standards of the International Society for the Advancement of Kinanthropometry (ISAK). Those variables will be used to describe the anthropometric profile (Heath and Carter somatotype, body composition through five-way fractionation method, muscle bone index, muscular adipose index, sum of skinfold thicknesses, and proportionality through Ross & Wilson Phantom strategy. Correspondences of those variables will also be established among different tests and specialties: sprint, middle-distance, long-distance, endurance, combined events, jumps, and throws. This study aims to provide the opportunity to generate reliable references for high-performance Mexican athletes.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

74

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Jalisco
      • Zapopan, Jalisco, Mexico, 45128
        • Iberoamerican Institute of Sports Science and Human Movement

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Elite and Olympic Mexican track and field athletes from different national teams and actively competing in national and international competitions

Description

Inclusion Criteria:

  • Elite and Olympic Mexican track and field athletes
  • Female and male,
  • All national teams
  • Actively competing in national and/or international competitions

Exclusion Criteria:

  • Injured or not classified athletes
  • Not informed consent signed

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Elite and Olympic Mexican track and field athletes
All 74 athletes competing in track and field events during the XXIV Central American and Caribbean Athletics Championship will be considered
A total of 43 anthropometric variables (complete profile) will be assessed following the guidelines of the International Society for the Advancement of Kinanthropometry. All measurements will be taken on the right side of the body. The full anthropometric profile will be undertaken in duplicate to establish retest reliability. If the difference between duplicate measures exceeds 5% for skinfolds or 1% for all other variables, a third measurement will be taken, but only after the full profile has been completed in duplicate. The mean of duplicate or median of triplicate anthropometric measurements will be used for all subsequent analysis. The intra-evaluator technical error of measurement (TEM) was calculated according to the 1996 protocol of Pederson and Gore.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Anthropometric body composition profile
Time Frame: One day
Body composition assessment through anthropometric five-way fractionation method of Ross and Kerr
One day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Heath and Carter somatotype
Time Frame: One day
A cuantitative method to assess body shape obtained from diferent anthropometric measurements
One day
Anthropometric profile
Time Frame: One day
A total of 43 measurements will be obtained using the standards of the methodology of the International Society for the Advancement of Kinanthropometry (ISAK)
One day
Muscle Bone Ratio
Time Frame: One day
Ratio between muscle mass and bone mass in Kg
One day
Muscular Adipose Ratio
Time Frame: One day
Ratio between muscle mass and adipose mass in Kg
One day
Sum of skinfold thicknesses
Time Frame: One day
Sum of 6 different skinfold thicknesses
One day
Corrected girths
Time Frame: One day
Correction of girth value by sustracting the skinfold thickness value
One day
Proportionality
Time Frame: One day
Ross phantom strategy for the analisys of body proportions
One day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Wiliam Carvajal-Veitía, PhD, Institute of Sports Medicine (IMD), Cuba
  • Principal Investigator: Fernando Alacid-Carceles, PhD, University of Almeria (UAL), Spain
  • Principal Investigator: Rodrigo Yáñez-Sepúlveda, PhD, Andres Bello University (UNAB), Chile

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 5, 2013

Primary Completion (Actual)

July 7, 2013

Study Completion (Actual)

July 7, 2013

Study Registration Dates

First Submitted

May 7, 2024

First Submitted That Met QC Criteria

May 10, 2024

First Posted (Actual)

May 16, 2024

Study Record Updates

Last Update Posted (Actual)

May 16, 2024

Last Update Submitted That Met QC Criteria

May 10, 2024

Last Verified

May 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • IICDEM-ID-001-2013

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Because the participants were informed that data management would be protected only by the principal investigators.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Athletes

Clinical Trials on Anthropometric assessment

Subscribe